Back to mobile site

Goldman Sachs Reiterates Sell Rating on 2Seventy Bio Inc. (TSVT)

November 12, 2024 12:52 PM EST Send to a Friend
Goldman Sachs analyst Salveen Richter reiterated a Sell rating and $2.00 price target on 2Seventy Bio Inc. (NASDAQ: TSVT).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login